Evidence map›Paper›PMID 42852204›Full record

ArticleMycology2026

AI-assisted systems pharmacology with experimental validation reveal multi-target anticancer mechanisms of

Haiyan Wang, Leilei Chen, Siqi Zhang, Mohan Ju, Junfeng Feng, Zixiang Tang, Jinwei Li, Hesham R El-Seedi, Yanbing Wang

Abstract read
In one paragraph

Article in Mycology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haiyan WangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0000-0002-9231-3869
Leilei ChenInstitute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0009-0009-7576-982X
Siqi ZhangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0000-9441-9475
Mohan JuSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0007-8891-2985
Junfeng FengSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0001-4816-6160
Zixiang TangSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0009-5412-2023
Jinwei LiSchool of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.ORCID https://orcid.org/0009-0006-0173-4585
Hesham R El-SeediDepartment of Chemistry, Faculty of Science, Islamic University of Madinah, Madinah, Saudi Arabia.ORCID https://orcid.org/0000-0002-2519-6690
Yanbing WangHealth Management Program, Boston University, Boston, USA.ORCID https://orcid.org/0000-0002-4164-1010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The medicinal fungus

Indexed as

Ganoderma lucidumimmune modulationlung cancermultitarget therapyPI3K-Akt-mTOR pathwaypolypharmacologySTAT3 signalingtumor microenvironment

Identifiers

PMID42852204
PMCPMC13647369

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.